Myocardial Regeneration via Progenitor Cell-Derived Exosomes

In the past 20 years, a variety of cell products has been evaluated in terms of their capacity to treat patients with acute myocardial infarction and chronic heart failure. Despite initial enthusiasm, therapeutic efficacy has overall been disappointing, and clinical application is costly and complex...

Descripción completa

Detalles Bibliográficos
Autores principales: Maring, Janita A., Beez, Christien M., Falk, Volkmar, Seifert, Martina, Stamm, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733225/
https://www.ncbi.nlm.nih.gov/pubmed/29333167
http://dx.doi.org/10.1155/2017/7849851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733225/
https://www.ncbi.nlm.nih.gov/pubmed/29333167
http://dx.doi.org/10.1155/2017/7849851

Ejemplares similares